据统计约有 80 %的原发性肝癌病人伴有不同程度的肝硬变 ,因此肝癌合并门静脉高压症在临床上并不少见[1] 。文献报道 ,肝癌病人合并食管胃底静脉曲张的发生率约为2 7%～ 35 7% ,约有 15 %～ 2 8%肝癌病人死于食管静脉曲张破裂出血 ,占肝癌直接死亡原因的第 2位。因此 ,在治疗 According to statistics, about 80% of patients with primary liver cancer are associated with varying degrees of cirrhosis. Therefore, it is not uncommon for hepatocellular carcinoma to be associated with portal hypertension [1]. Reported in the literature, the incidence of hepatocellular carcinoma patients with esophageal varices is about 27% to 35 7%, about 15% to 28% of liver cancer patients died of esophageal variceal bleeding, accounting for the direct cause of death of liver cancer 2 Bit. Therefore, in treatment